Luchs J - Search Results

1

Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.

Tauber J, Karpecki P, Latkany R, Luchs J, Martel J, Sall K, Raychaudhuri A, Smith V, Semba CP; OPUS-2 Investigators. Tauber J, et al. Among authors: luchs j. Ophthalmology. 2015 Dec;122(12):2423-31. doi: 10.1016/j.ophtha.2015.08.001. Epub 2015 Sep 11. Ophthalmology. 2015. PMID: 26365210 Free article. Clinical Trial.

2

Elestat (epinastine HCl ophthalmic solution 0.05%) as a therapeutic for allergic conjunctivitis.

Trattler WB, Luchs J, Majmudar P. Trattler WB, et al. Among authors: luchs j. Int Ophthalmol Clin. 2006 Fall;46(4):87-99. doi: 10.1097/01.iio.0000212136.77675.b1. Int Ophthalmol Clin. 2006. PMID: 17060795 Review. No abstract available.

3

Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry.

Luchs JI, Nelinson DS, Macy JI; LAC-07-01 Study Group. Luchs JI, et al. Cornea. 2010 Dec;29(12):1417-27. doi: 10.1097/ICO.0b013e3181e3f05b. Cornea. 2010. PMID: 20847657 Clinical Trial.

4

Making the diagnosis of Sjögren's syndrome in patients with dry eye.

Beckman KA, Luchs J, Milner MS. Beckman KA, et al. Among authors: luchs j. Clin Ophthalmol. 2015 Dec 24;10:43-53. doi: 10.2147/OPTH.S80043. eCollection 2016. Clin Ophthalmol. 2015. PMID: 26766898 Free PMC article. Review.

5

Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3).

Holland EJ, Luchs J, Karpecki PM, Nichols KK, Jackson MA, Sall K, Tauber J, Roy M, Raychaudhuri A, Shojaei A. Holland EJ, et al. Among authors: luchs j. Ophthalmology. 2017 Jan;124(1):53-60. doi: 10.1016/j.ophtha.2016.09.025. Epub 2016 Oct 27. Ophthalmology. 2017. PMID: 28079022 Free article. Clinical Trial.

6

Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.

Milner MS, Beckman KA, Luchs JI, Allen QB, Awdeh RM, Berdahl J, Boland TS, Buznego C, Gira JP, Goldberg DF, Goldman D, Goyal RK, Jackson MA, Katz J, Kim T, Majmudar PA, Malhotra RP, McDonald MB, Rajpal RK, Raviv T, Rowen S, Shamie N, Solomon JD, Stonecipher K, Tauber S, Trattler W, Walter KA, Waring GO 4th, Weinstock RJ, Wiley WF, Yeu E. Milner MS, et al. Among authors: luchs ji. Curr Opin Ophthalmol. 2017 Jan;27 Suppl 1(Suppl 1):3-47. doi: 10.1097/01.icu.0000512373.81749.b7. Curr Opin Ophthalmol. 2017. PMID: 28099212 Free PMC article. Review.

7

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease.

Tauber J, Schechter BA, Bacharach J, Toyos MM, Smyth-Medina R, Weiss SL, Luchs JI. Tauber J, et al. Among authors: luchs ji. Clin Ophthalmol. 2018 Oct 2;12:1921-1929. doi: 10.2147/OPTH.S175065. eCollection 2018. Clin Ophthalmol. 2018. PMID: 30323548 Free PMC article.

8

Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease.

Yeu E, Goldberg DF, Mah FS, Beckman KA, Luchs JI, Solomon JD, White DE, Gupta PK. Yeu E, et al. Clin Ophthalmol. 2019 May 27;13:887-894. doi: 10.2147/OPTH.S203510. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31213759 Free PMC article.

9

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies.

Malhotra R, Devries DK, Luchs J, Kabat A, Schechter BA, Shen Lee B, Shettle L, Smyth-Medina R, Ogundele A, Darby C, Bacharach J, Karpecki P. Malhotra R, et al. Among authors: luchs j. Cornea. 2019 Oct;38(10):1259-1265. doi: 10.1097/ICO.0000000000001989. Cornea. 2019. PMID: 31306284 Free PMC article. Clinical Trial.

10

Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials.

Smyth-Medina R, Johnston J, Devries DK, Jasper A, Kannarr SR, Schechter BA, Shen Lee B, Varghese G, Ogundele A, Darby CH, Karpecki P, Luchs J. Smyth-Medina R, et al. Among authors: luchs j. J Ocul Pharmacol Ther. 2019 Sep;35(7):388-394. doi: 10.1089/jop.2018.0154. Epub 2019 Aug 2. J Ocul Pharmacol Ther. 2019. PMID: 31373837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters